scispace - formally typeset
O

Omid C. Farokhzad

Researcher at Brigham and Women's Hospital

Publications -  340
Citations -  75194

Omid C. Farokhzad is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Drug delivery & Aptamer. The author has an hindex of 110, co-authored 329 publications receiving 64226 citations. Previous affiliations of Omid C. Farokhzad include Beth Israel Deaconess Medical Center & Columbia University.

Papers
More filters
Journal ArticleDOI

Nanoparticles in Medicine: Therapeutic Applications and Developments

TL;DR: Nanomaterials have unique physicochemical properties, such as ultra small size, large surface area to mass ratio, and high reactivity, which are different from bulk materials of the same composition, which can be used to overcome some of the limitations found in traditional therapeutic and diagnostic agents.
Journal ArticleDOI

Cancer Nanotechnology: The impact of passive and active targeting in the era of modern cancer biology

TL;DR: The fundamental concepts of enhanced permeability and retention effect (EPR) are revisited and the mechanisms proposed to enhance preferential "retention" in the tumor, whether using active targeting of nanoparticles, binding of drugs to their tumoral targets or the presence of tumor associated macrophages are explored.
Journal ArticleDOI

Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo

TL;DR: The potential utility of nanoparticle-aptamer bioconjugates for a therapeutic application is demonstrated and remarkable efficacy and reduced toxicity as measured by mean body weight loss (BWL) in vivo are demonstrated.